Biomarkers in Urology, An Issue of Urologic Clinics

— —

Adam Feldman, MD, MPH (Assistant Professor, Surgery, Harvard Medical School, Assistant in Urology, Urology, Massachusetts General Hospital, Harvard University, Dana-Farber/Harvard Cancer Center)

Biomarkers in Urology, An Issue of Urologic Clinics

Adam Feldman, MD, MPH (Assistant Professor, Surgery, Harvard Medical School, Assistant in Urology, Urology, Massachusetts General Hospital, Harvard University, Dana-Farber/Harvard Cancer Center)

$194.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Elsevier - Health Sciences Division
23 November 2022

Urology & urogenital medicine

Series: The Clinics: Surgery

In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology.

Contains 15 practice-oriented topics including biomarkers in pediatric urology; unleashing the urinary microbiome in benign urologic disease; biomarkers for detection and assessment of clinically significant prostate cancer; biomarkers in testicular cancer: classic tumor markers and beyond; and more.

Provides in-depth clinical reviews on biomarkers in urology, offering actionable insights for clinical practice.

Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Edited by: Adam Feldman MD MPH (Assistant Professor Surgery Harvard Medical School Assistant in Urology Urology Massachusetts General Hospital Harvard University Dana-Farber/Harvard Cancer Center)
Imprint: Elsevier - Health Sciences Division
Country of Publication: United States
Dimensions: Height: 254mm, Width: 178mm,
Weight: 540g
ISBN: 9780323940191
ISBN 10: 0323940196
Series: The Clinics: Surgery
Pages: 240
Publication Date: 23 November 2022
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Approaches and Barriers to Biomarker Discovery: The Example of Biomarkers of Renal Scarring in Pediatric Urology Biomarkers in Urolithiasis Biomarkers in Urethral Stricture Disease and Benign Lower Urinary Tract Disease Pathophysiology and Clinical Biomarkers in Interstitial Cystitis Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-Muscle-Invasive Bladder Cancer Biological Stratification of Invasive and Advanced Urothelial Carcinoma The Association Between the Urinary Microbiome and Bladder Cancer Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers Targeted Molecular Imaging as a Biomarker in Urologic Oncology Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer Current and Future Biomarkers in the Management of Renal Cell Carcinoma

WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Biomarkers in Urology, An Issue of Urologic Clinics

Adam Feldman, MD, MPH (Assistant Professor, Surgery, Harvard Medical School, Assistant in Urology, Urology, Massachusetts General Hospital, Harvard University, Dana-Farber/Harvard Cancer Center)

$194.95

Hardback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S